more new indications so out could gain fda approval to treat more diseases. you know what? seems like a terrific story to me, right? what went wrong? what do people hate about it? why did it get clobbered over the course of july? okay. there had always been a shot of short sellers betting against this one. 44% of the shares outstanding have been sold sort. that's a figure that says people think this is a joke. get out of there. but for the most part -- ooh, eagles helmet -- but for the most part, the shorts were getting their heads handed to them until july. when a bunch of websites started to report rumors about potential competition. for questcor's one and only product. that's how it went from 35 to 52